HGN-79981-87508
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 085 / NJ
- Registered
- 2021-11-24
- Relationship
- Child or adolescent in my care
- Guardian
- YRQ-29429-07969
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-18
Dose 1 — Pfizer-BioNTech
-
2021-11-24
Registered in v-safe
- 2021-11-24
- 2021-11-25
- 2021-12-02
-
2021-12-09
Dose 2 — Pfizer-BioNTech
- 2021-12-09
-
2021-12-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-23
- 2022-01-06
-
2022-01-13
Survey response — day 35, dose 2, dependentMedDRA: Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat, sneezing, runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-20
- 2022-03-10
- 2022-06-09
- 2022-12-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-18 | Pfizer-BioNTech | No |
| 2 | 2021-12-09 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 2, dependent
Symptoms: Sore throat, sneezing, runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release